Unlock instant, AI-driven research and patent intelligence for your innovation.

An integrated nanosystem and preparation method for liver-targeted co-delivery of genes/drugs

A liver-targeting, copolymer technology, applied in the field of biomedicine, can solve the problem of underutilization, and achieve the effect of promoting real-time imaging, low cytotoxicity, and reducing drug leakage

Active Publication Date: 2019-06-07
JIANGNAN UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Although there have been many related studies in order to obtain nanomaterials that can achieve the co-delivery of nucleic acids and anticancer drugs, these systems for liver cancer therapy have not been fully utilized. There is no report on the nucleic acid and anticancer drug co-delivery carrier, and it is still a challenge to integrate multiple functions into the same nanocarrier for targeted therapy of liver cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • An integrated nanosystem and preparation method for liver-targeted co-delivery of genes/drugs
  • An integrated nanosystem and preparation method for liver-targeted co-delivery of genes/drugs
  • An integrated nanosystem and preparation method for liver-targeted co-delivery of genes/drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] Embodiment 1: the preparation of bromorhodamine B initiator

[0060] Weigh 15.52g (25.00mmol) of ethylene glycol and 1.01g (10.00mmol) of triethylamine in a 100mL Erlenmeyer flask, stir in an ice-water bath to 0°C, and add 1.20mL (10.00mmol) of 2 -Bromoisobutyryl bromide, then slowly warmed up to room temperature, and magnetically stirred for 3h. The reacted solution was quenched by adding 100 mL of deionized water, and then extracted with dichloromethane (100 mL×3). The collected organic phases were extracted with deionized water (100 mL×3). An appropriate amount of anhydrous magnesium sulfate was added to the extracted organic phase, and dried for 12 hours. After filtration, the oily crude product was obtained by rotary evaporation, and the product was distilled under reduced pressure (85°C, 30mTorr) to obtain a colorless viscous product, hydroxyethyl isobromobutyrate.

[0061] Get 4.81g (10.00mmol) rhodamine B, 2.90g (15.00mmol) 1-ethyl-(3-dimethylaminopropyl) car...

Embodiment 2

[0062] Example 2: 3-Azido-2-hydroxypropyl methacrylate GMA-N 3 preparation of

[0063]Dissolve 3.71g (57.00mmol) sodium azide, 3.81g (45.20mmol) sodium bicarbonate in 60mL tetrahydrofuran / water (5:1v / v) and stir, slowly add 5.42g (37.80mmol) glycidyl methacrylate Ester, reaction at room temperature for 48h. After removing the insoluble salt by filtration, the solvent was removed by rotary evaporation, and the obtained concentrate was extracted twice with dichloromethane, and then the obtained organic phase was dried and filtered with anhydrous magnesium sulfate, the solvent was removed by rotary evaporation, and the solvent was passed through a silica gel column (eluent : n-hexane / ethyl acetate volume ratio=9:1) separated to obtain 3-azido-2-hydroxyl propyl methacrylate. For specific methods, reference can be made to literature (Polymer Chemistry, 2015, 6, 3875-3884; Soft Matter, 2009, 5, 4788-4796).

Embodiment 3

[0064] Embodiment 3: Rhodamine B modified copolymer (RhB-PDMAEMA25-c-PGMA50-N 3 ) preparation

[0065] Accurately weigh 70.0mg (0.10mmol) bromorhodamine B initiator, 484.0mg (2.75mmol) monomer DMAEMA and 1.01g (5.50mmol) compound 3-azido-2-hydroxypropyl methacrylate and add to 25mL In a round bottom flask, dissolve with 2mL tetrahydrofuran, and pass argon gas for 30 minutes to remove oxygen in the flask. Wherein the monomer DMAEMA needs to remove the stabilizing agent therein in advance, is about to pass the DMAEMA crude product through the basic alumina column quickly. Under the protection of nitrogen, 18.9 mg (0.10 mmol) of CuBr and PMDETA (28 μL, 0.10 mmol) were successively added, the flask was sealed, and the reaction was carried out at room temperature for 8 h under the protection of nitrogen. After the reaction is over, add tetrahydrofuran (10 mL) to the reaction solution, fully stir and dissolve the reaction solution in the bottle, pass through a neutral alumina colu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses an integrated nano system and a preparation method for liver-targeted co-delivery of genes / drugs, belonging to the field of biomedicine. The present invention integrates multiple functions in a carrier with good biocompatibility and safety, and the nucleic acid / drug-loaded copolymer part [grafted with poly(3-azido-2-hydroxyl Propyl methacrylate) (PGMA‑N 3 ), composed of poly(N,N-dimethylaminoethyl methacrylate (PDMAEMA)]), the fluorescence-based imaging component rhodamine B (RhB), and galactose as the targeting ligand. The drug delivery system provided by the invention is safe, can exert the synergistic effect of gene / drug therapy, and is expected to play a huge role in clinical application.

Description

technical field [0001] The invention relates to an integrated nanosystem and preparation method for liver-targeted co-delivery of genes / drugs, in particular to a copolymer nanomicelle capable of loading nucleic acid substances and drugs with liver tumor tissue targeting and traceability , belonging to the field of biomedicine. Background technique [0002] Liver cancer has been the second most common leading cause of cancer-related death worldwide for decades, with approximately 750,000 new cases each year. Moreover, the morbidity and mortality of liver cancer are increasing year by year, which seriously threatens the health and life of people in my country and even the world. The high rates of liver cancer morbidity and mortality are largely attributable to the late diagnosis of the disease and the limited available treatments. Additionally, surgical treatment is not suitable for most patients due to the lack of available transplant donors. Therefore, it is imminent to d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/107A61K47/32A61K47/22A61K47/26A61K31/704A61K31/7105A61K48/00A61P35/00
CPCA61K9/1075A61K31/704A61K31/7105A61K47/22A61K47/26A61K47/32A61K2300/00A61P35/00
Inventor 尹健胡静彼特·泽贝格叶舟
Owner JIANGNAN UNIV